Biotech News
-
Zentek Files Amended and Restated Audited Financial Statements
November 4, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated…
-
Sixth Wave AMIPs(TM) Expands Detection Capabilities to Include Prevalent Foodborne Pathogens Salmonella and Listeria
November 1, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or…
-
Voyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for Customers
October 31, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC: VYYRF) (the “Company” or “Voyageur”) announces the completion of…
-
Zentek Provides Update on Battery Technology Development
October 28, 2022 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces…
-
Hemostemix Announces Dr. Giannetti and Dr. Cecere as Co-Lead Medical Consultants, Cardiovascular Clinical Trials
October 26, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) (“Hemostemix” or the “Company”) is pleased…
-
Sixth Wave Innovations Inc. Granted Additional MIPS Patent for Extraction and Purification of Metals
October 26, 2022 (Source) – Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: SIXWF) (FSE: AHUH) (“Sixth Wave”, “SIXW” or the…
-
Hemostemix Announces Presentation to the Emerging Growth Conference
October 25, 2022 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (“Hemostemix” or the “Company”) invites shareholders, brokers and…
-
Cardiol Therapeutics Prioritizes Phase II Clinical Programs in Underserved Heart Diseases
Discontinues LANCER Trial due to Lack of Eligible Patients for Recruitment Cash Runway Now Extends into 2026 October…
-
Voyageur Pharmaceuticals Ltd. Signs an MOU for the Development of Carbon Fullerene Contrast Agents for Medical Imaging Applications and Related Carbon Capture Technology
October 24, 2022 (Source) – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the “Company” or “Voyageur”) has signed a memorandum of…
-
Sona Announces Commercial Agreement with Siva Therapeutics
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
